Treatment Persistence Between Long-Acting Injectable versus Oral Aripiprazole among Patients with Schizophrenia in a Real-World Clinical Setting in Japan
figure
posted on 2020-06-02, 13:28 authored by Nakao Iwata, Ataru Inagaki, Hiromi Sano, Kazunari Niidome, Yoshitsugu Kojima, Sakiko Yamada<p>The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.<b>
</b></p>
History
Related Materials
- 1.
- 2.
